The prolyl hydroxylase PHD3 identifies proinflammatory macrophages and its expression is regulated by activin A

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1946-1954

  Escribese, María M ^a   Sierra Filardi, Elena ^a   Nieto, Concha ^a   Samaniego, Rafael ^b   Sánchez Torres, Carmen ^c   Matsuyama, Takami ^d   Calderon Gómez, Elisabeth ^e   Vega, Miguel A ^a   Salas, Azucena ^e   Sánchez Mateos, Paloma ^b   Corbí, Angel L ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CD163 ANTIGEN; CELL MARKER; COLONY STIMULATING FACTOR 1; FOLATE RECEPTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE 3; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL HYPOXIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROHN DISEASE; EGLN3 GENE; ENZYME LOCALIZATION; GENE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MELANOMA; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE DISTRIBUTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION; ULCERATIVE COLITIS; UPREGULATION;

ACTIVINS; BLOTTING, WESTERN; DIOXYGENASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MICROSCOPY, CONFOCAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864797376     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201064     Document Type: Article

References (56)

1. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964. (Pubitemid 41746764)
2. Biswas, S. K., and A. Mantovani. 2010. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11: 889-896.
3. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565. (Pubitemid 38437450)
4. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544. (Pubitemid 351913679)
5. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252. (Pubitemid 46595309)
6. Takeda, N., E. L. O'Dea, A. Doedens, J. W. Kim, A. Weidemann, C. Stockmann, M. Asagiri, M. C. Simon, A. Hoffmann, and R. S. Johnson. 2010. Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24: 491-501.
7. Semenza, G. L. 2001. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7: 345-350. (Pubitemid 32735019)
8. Vaupel, P., and M. Höckel. 2003. Tumor oxygenation and its relevance to tumor physiology and treatment. Adv. Exp. Med. Biol. 510: 45-49. (Pubitemid 36307752)
9. Le, Q. T., N. C. Denko, and A. J. Giaccia. 2004. Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 23: 293-310.
10. Harris, A. L. 2002. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2: 38-47. (Pubitemid 37328806)
11. Pugh, C. W., and P. J. Ratcliffe. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9: 677-684. (Pubitemid 36749216)
12. Sitkovsky, M., and D. Lukashev. 2005. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat. Rev. Immunol. 5: 712-721. (Pubitemid 43086172)
13. Burke, B., A. Giannoudis, K. P. Corke, D. Gill, M. Wells, L. Ziegler-Heitbrock, and C. E. Lewis. 2003. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 163: 1233-1243. (Pubitemid 37175073)
14. Talks, K. L., H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe, and A. L. Harris. 2000. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157: 411-421. (Pubitemid 30626905)
15. Yu, F., S. B. White, Q. Zhao, and F. S. Lee. 2001. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98: 9630-9635. (Pubitemid 32769354)
16. Epstein, A. C., J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, M. Mukherji, E. Metzen, M. I. Wilson, A. Dhanda, et al. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54. (Pubitemid 32972036)
17. Maxwell, P. H., M. S. Wiesener, G. W. Chang, S. C. Clifford, E. C. Vaux, M. E. Cockman, C. C. Wykoff, C. W. Pugh, E. R. Maher, and P. J. Ratcliffe. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275. (Pubitemid 29246458)
18. Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340. (Pubitemid 33063099)
19. Metzen, E. 2007. Enzyme substrate recognition in oxygen sensing: how the HIF trap snaps. Biochem. J. 408: e5-e6.
20. Wax, S. D., C. L. Rosenfield, and M. B. Taubman. 1994. Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J. Biol. Chem. 269: 13041-13047. (Pubitemid 24202110)
21. Su, Y., M. Loos, N. Giese, O. J. Hines, I. Diebold, A. Görlach, E. Metzen, S. Pastorekova, H. Friess, and P. Büchler. 2010. PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer.Br. J. Cancer 103: 1571-1579.
22. Luo, W., H. Hu, R. Chang, J. Zhong, M. Knabel, R. O'Meally, R. N. Cole, A. Pandey, and G. L. Semenza. 2011. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732-744.
23. Tennant, D. A., and E. Gottlieb. 2010. HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate- induced apoptosis and tumor suppression. J. Mol. Med. 88: 839-849.
24. Xue, J., X. Li, S. Jiao, Y. Wei, G. Wu, and J. Fang. 2010. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology 138: 606-615.
25. Pescador, N., Y. Cuevas, S. Naranjo, M. Alcaide, D. Villar, M. O. Landázuri, and L. Del Peso. 2005. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390: 189-197. (Pubitemid 41192244)
26. Ross, J. F., H. Wang, F. G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam. 1999. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85: 348-357. (Pubitemid 29051289)
27. Puig-Kröger, A., E. Sierra-Filardi, A. Domínguez-Soto, R. Samaniego, M. T. Corcuera, F. Gómez-Aguado, M. Ratnam, P. Sánchez-Mateos, and A. L. Corbí. 2009. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. 69: 9395-9403.
28. Sierra-Filardi, E., M. A. Vega, P. Sánchez-Mateos, A. L. Corbí, and A. Puig- Kröger. 2010. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215: 788-795.
29. Sierra-Filardi, E., A. Puig-Kröger, F. J. Blanco, C. Nieto, R. Bragado, M. I. Palomero, C. Bernabéu, M. A. Vega, and A. L. Corbí. 2011. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117: 5092-5101.
30. Ruffell, B., N. I. Affara, and L. M. Coussens. 2012. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 33: 119-126.
31. D'Angelo, G., E. Duplan, N. Boyer, P. Vigne, and C. Frelin. 2003. Hypoxia upregulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J. Biol. Chem. 278: 38183-38187. (Pubitemid 37221706)
32. Bosco, M. C., M. Puppo, F. Blengio, T. Fraone, P. Cappello, M. Giovarelli, and L. Varesio. 2008. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration. Immunobiology 213: 733-749.
33. Metzen, E., U. Berchner-Pfannschmidt, P. Stengel, J. H. Marxsen, I. Stolze, M. Klinger, W. Q. Huang, C. Wotzlaw, T. Hellwig-Bürgel, W. Jelkmann, et al. 2003. Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J. Cell Sci. 116: 1319-1326. (Pubitemid 36410669)
34. Place, T. L., M. P. Fitzgerald, S. Venkataraman, S. U. Vorrink, A. J. Case, M. L. Teoh, and F. E. Domann. 2011. Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells. PLoS ONE 6: e14617.
35. Frank, D., J. Gantenberg, I. Boomgaarden, C. Kuhn, R. Will, K. U. Jarr, M. Eden, K. Kramer, M. Luedde, H. Mairbäurl, et al. 2012. MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3. J. Mol. Cell. Cardiol. 52: 711-717.
36. Bozec, A., L. Bakiri, A. Hoebertz, R. Eferl, A. F. Schilling, V. Komnenovic, H. Scheuch, M. Priemel, C. L. Stewart, M. Amling, and E. F. Wagner. 2008. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 454: 221-225. (Pubitemid 351969891)
37. Sánchez-Elsner, T., L. M. Botella, B. Velasco, A. Corbí, L. Attisano, and C. Bernabéu. 2001. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276: 38527-38535.
38. Mukerji, S. S., E. A. Katsman, C. Wilber, N. A. Haner, W. R. Selman, and A. K. Hall. 2007. Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice. J. Cereb. Blood Flow Metab. 27: 1161-1172. (Pubitemid 46808705)
39. Zhou, W., M. Choi, D. Margineantu, L. Margaretha, J. Hesson, C. Cavanaugh, C. A. Blau, M. S. Horwitz, D. Hockenbery, C. Ware, and H. Ruohola-Baker. 2012. HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J. 31: 2103-2116.
40. Mantovani, A., A. Sica, and M. Locati. 2005. Macrophage polarization comes of age. Immunity 23: 344-346. (Pubitemid 41443435)
41. Lacey, D. C., A. Achuthan, A. J. Fleetwood, H. Dinh, J. Roiniotis, G. M. Scholz, M. W. Chang, S. K. Beckman, A. D. Cook, and J. A. Hamilton. 2012. Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models. J. Immunol. 188: 5752-5765.
42. Denning, T. L., Y. C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8: 1086-1094. (Pubitemid 47423756)
43. Jones, K. L., A. Mansell, S. Patella, B. J. Scott, M. P. Hedger, D. M. de Kretser, and D. J. Phillips. 2007. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc. Natl. Acad. Sci. USA 104: 16239-16244. (Pubitemid 350099391)
44. Phillips, D. J., D. M. de Kretser, and M. P. Hedger. 2009. Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev. 20: 153-164.
45. Takeda, K., T. Ichiki, E. Narabayashi, K. Inanaga, R. Miyazaki, T. Hashimoto, H. Matsuura, J. Ikeda, T. Miyata, and K. Sunagawa. 2009. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide- induced TNF-alpha expression. Arterioscler. Thromb. Vasc. Biol. 29: 2132-2137.
46. Domínguez-Soto, A., E. Sierra-Filardi, A. Puig-Kröger, B. Pérez-Maceda, F. Gómez-Aguado, M. T. Corcuera, P. Sánchez-Mateos, and A. L. Corbí. 2011. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10. J. Immunol. 186: 2192-2200.
47. Gallina, G., L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, M. P. Colombo, G. Basso, F. Brombacher, I. Borrello, P. Zanovello, et al. 2006. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116: 2777-2790. (Pubitemid 44511641)
48. Movahedi, K., D. Laoui, C. Gysemans, M. Baeten, G. Stangé, J. Van den Bossche, M. Mack, D. Pipeleers, P. In't Veld, P. De Baetselier, and J. A. Van Ginderachter. 2010. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70: 5728-5739.
49. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
50. Hirschhaeuser, F., U. G. Sattler, and W. Mueller-Klieser. 2011. Lactate: a metabolic key player in cancer. Cancer Res. 71: 6921-6925.
51. Rodríguez-Prados, J. C., P. G. Través, J. Cuenca, D. Rico, J. Aragonés, P. Martín-Sanz, M. Cascante, and L. Boscá. 2010. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185: 605-614.
52. Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364: 656-665.
53. Doedens, A. L., C. Stockmann, M. P. Rubinstein, D. Liao, N. Zhang, D. G. DeNardo, L. M. Coussens, M. Karin, A. W. Goldrath, and R. S. Johnson. 2010. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 70: 7465-7475.
54. Majmundar, A. J., W. J. Wong, and M. C. Simon. 2010. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40: 294-309.
55. Ginouvès, A., K. Ilc, N. Macías, J. Pouysségur, and E. Berra. 2008. PHDs overactivation during chronic hypoxia " desensitizes" HIFalpha and protects cells from necrosis. Proc. Natl. Acad. Sci. USA 105: 4745-4750. (Pubitemid 351753817)
56. Walmsley, S. R., E. R. Chilvers, A. A. Thompson, K. Vaughan, H. M. Marriott, L. C. Parker, G. Shaw, S. Parmar, M. Schneider, I. Sabroe, et al. 2011. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest. 121: 1053-1063.